Deb Feldman-Stewart
Overview
Explore the profile of Deb Feldman-Stewart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bender J, Feldman-Stewart D, Tong C, Lee K, Brundage M, Pai H, et al.
J Med Internet Res
. 2019 Nov;
21(11):e14241.
PMID: 31742561
Background: After a prostate cancer diagnosis, men want information about their disease and treatment options. The internet offers a convenient means to deliver health information to patients with prostate cancer....
2.
Thavarajah N, McGuffin M, Prospero L, Fitch M, Harth T, Feldman-Stewart D, et al.
J Med Imaging Radiat Sci
. 2019 May;
46(2):189-196.
PMID: 31052093
Introduction: There is currently no consensus regarding the optimal treatment for postprostatectomy prostate cancer patients. The primary objective of this study was to investigate patient opinions regarding the questions that...
3.
Chun-Leung Chau D, Wang D, Tedesco A, McGuffin M, Prospero L, Fitch M, et al.
J Med Imaging Radiat Sci
. 2019 May;
47(1):108-112.e2.
PMID: 31047156
Introduction: With locally advanced, recurrent, and metastatic prostate cancer patients, patient preference between intermittent (IAD) and continuous (CAD) androgen deprivation therapy has not been investigated. The goal of the study...
4.
Brennan K, Hall S, Yoo J, Rohland S, Theurer J, Peng Y, et al.
Eur J Cancer Care (Engl)
. 2019 Jan;
28(2):e12993.
PMID: 30656777
Objective: The experience of a cancer diagnosis and receiving treatment can have profound impacts on health and subsequently patients may require significant support. Often, these needs are not identified or...
5.
Bonin K, McGuffin M, Lechtman E, Cumal A, Harth T, Calabrese E, et al.
J Med Imaging Radiat Sci
. 2018 Dec;
49(4):365-370.
PMID: 30514552
Introduction: Radiation therapy (RT) after prostatectomy is an important curative treatment option for patients with prostate cancer. It can be delivered immediately after surgery as adjuvant treatment, or after biochemical...
6.
Feldman-Stewart D, Tong C, Brundage M, Bender J, Robinson J
Can Urol Assoc J
. 2018 Jul;
12(10):337-343.
PMID: 29989912
Introduction: We sought to determine the experiences and preferences of prostate cancer patients related to the process of making their treatment decisions, and to the use of decision support. Methods:...
7.
Walker M, Doiron R, French S, Brennan K, Feldman-Stewart D, Siemens D, et al.
Bladder Cancer
. 2018 Feb;
4(1):49-65.
PMID: 29430507
Background: Utilization of chemotherapy for patients with muscle-invasive bladder cancer (MIBC) is low. In earlier qualitative work we used the Theoretical Domains Framework (TDF) to determine barriers and enablers of...
8.
Feldman-Stewart D, Tong C, Brundage M, Bender J, Robinson J
Can Urol Assoc J
. 2018 Feb;
12(5):E219-E225.
PMID: 29405903
Introduction: Prostate cancer patients' information needs are well-described, but little is known about their preferred sources and media for obtaining information. We sought to determine prostate cancer patients' experiences and...
9.
Walker M, Doiron R, French S, Feldman-Stewart D, Siemens D, Mackillop W, et al.
Can Urol Assoc J
. 2018 Jan;
12(4):E182-E190.
PMID: 29319482
Introduction: Use of chemotherapy for muscle-invasive bladder cancer (MIBC) is known to be low. To understand factors driving practice we use the Theoretical Domains Framework (TDF) to identify barriers and...
10.
Walker M, French S, Doiron R, Brennan K, Feldman-Stewart D, Siemens D, et al.
Radiother Oncol
. 2017 Oct;
125(2):351-356.
PMID: 28974310
Background: To understand barriers and enablers to use of curative-intent radiotherapy (RT) for muscle-invasive bladder cancer using the Theoretical Domains Framework (TDF). Methods: Canadian urologists, radiation oncologists (ROs) and medical...